Over the past quarter, BioAdaptives has focused on securing high-quality, standardized raw materials and establishing partnerships with GMP-compliant manufacturing facilities. These steps ensure the ...
PR Newswire TEL AVIV, Israel and OSLO, Norway, July 20, 2026 TEL AVIV, Israel and OSLO, Norway, July 20, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinica ...
St. Jude-led researchers just landed a major federal lift that could push cutting-edge gene-editing therapies out of the lab ...
BioAdaptives detailed the strategy behind its Xcellara platform, combining stem cell mobilization with tissue-targeting ...
BioAdaptives® Inc. (OTC: BDPT) today outlined the scientific strategy behind its Xcellara™ cellular wellness platform ahead of the August 1, 2026, commercial launch of XcellaraHeart™. The platform ...
The formula combines the Xcellara™ mobilization base with Tanshinone IIA, a Danshen-derived compound studied for its effects on the SDF-1α/CXCR4 signaling pathways involved in cellular trafficking and ...
Activating YAP/TAZ signaling with a novel small molecule accelerated hematopoietic regeneration and promoted stem cell ...
A healthy bone marrow (BM) produces nearly all types of cells in our blood. Many blood disorders occur when hematopoietic ...
A healthy bone marrow (BM) produces nearly all types of cells in our blood. Many blood disorders occur when hematopoietic ...
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results